分组1 - Weili Medical plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, based on an undistributed profit of 704 million yuan as of September 30, 2025 [1] - Tongding Interconnect's shareholder plans to reduce their stake by up to 0.49%, equating to a maximum of 605,800 shares [1] - Caitong Securities has received approval from the China Securities Regulatory Commission to issue short-term corporate bonds with a total face value of up to 5 billion yuan [1] 分组2 - Youfu Food intends to use 70 million yuan of its own funds to invest in wealth management products with expected annual returns of up to 4.2% [3] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [5] - Ouma Software's controlling shareholder has completed the transfer of state-owned equity, changing the controlling shareholder to Shandong Guotou [7] 分组3 - ST Huapeng's wholly-owned subsidiary has completed a major overhaul project and is now in production [8] - Beiqi Blue Valley has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [8] - Weijie Chuangxin received a government subsidy of 5 million yuan, accounting for 21.07% of its projected net profit for 2024 [9] 分组4 - China Resources Double Crane's subsidiary has received a drug registration certificate for a hypertension treatment drug [11] - Huafeng shares are continuing to suspend trading due to a planned change in control [13] - Kaifa Electric's shareholder plans to transfer 36.6869 million shares, representing 11.63% of the total share capital [14] 分组5 - Heng Rui Medicine has received approval for two clinical trials for innovative anti-tumor drugs [15] - Kosen Technology plans to invest 30 million USD to establish a new production base in Malaysia [17] - Sanxing Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 107 million yuan [18] 分组6 - Sitai Li's subsidiary has received a drug registration certificate for a contrast agent used in MRI [21] - Daren Tang's subsidiary has received a drug registration certificate for a pain relief gel [22] - Saike Xide has received approval for three medical device products, expanding its product range in the in vitro diagnostic field [23] 分组7 - Hasa Lian has elected a new chairman and vice chairman for its board of directors [24] - Two-sided Needle's subsidiary plans to invest 68.8522 million yuan in a production base expansion project [25] - Sunshine Nuohe plans to transfer 70% of its controlling subsidiary's equity for 2 million yuan [26] 分组8 - Hengbang shares received an administrative regulatory decision from the Shandong Securities Regulatory Bureau for failing to complete the election of independent directors [27] - Huali shares plan to sign a related transaction contract worth approximately 59.2847 million yuan [28] - Shangwei shares plan to invest 520.4 million yuan to gain a controlling stake in Sichuan Zhongfu Taihua [30] 分组9 - Zejing Pharmaceutical's ZG006 has been included in the list of breakthrough therapeutic varieties for treating advanced neuroendocrine cancer [32] - Yaopi Glass's shareholder plans to reduce their stake by up to 2.26%, equating to a maximum of 21.1469 million shares [34] - Huate Gas has initiated a major lawsuit involving a claim of 180 million yuan [36] 分组10 - Zhongchumei's controlling shareholder plans to increase their stake by between 42 million and 80 million yuan [37] - Huitong shares' shareholder plans to reduce their stake by up to 1% [38] - Miaowei Exhibition plans to apply for an initial public offering of H shares on the Hong Kong Stock Exchange [40] 分组11 - Tianqi Lithium's subsidiary has appealed to the Chilean Supreme Court regarding a partnership agreement with SQM and Codelco [42] - Naxin Micro plans to repurchase shares worth between 200 million and 400 million yuan [44] - Pingao shares have reported significant uncertainty regarding future business development and profitability [46] 分组12 - Shunyu shares have been pre-selected for a project worth 1.023 billion yuan [48] - Zhongyuan Neipei plans to acquire a 2.5% share in an aerospace industry fund for 50 million yuan [50] - Huifa Food's shareholder plans to reduce their stake by up to 3%, equating to a maximum of 727.14 million shares [53] 分组13 - Junshi Biosciences' subcutaneous PD-1 new formulation has reached its primary endpoint in a Phase III clinical trial [54] - Industrial Fulian clarified that it has not lowered its fourth-quarter profit target amid market rumors [55] - Longpan Technology's subsidiary has signed a major supply agreement for lithium iron phosphate materials, significantly increasing the supply volume [56]

Group 1 - The Shenzhen Stock Exchange issued a regulatory letter to Shandong Hengbang Smelting Co., Ltd. regarding the resignation of independent directors Huang Jianbo and Jiao Jian, which resulted in the number of independent directors falling below one-third of the board members [1] - The company failed to complete the necessary election of new independent directors within the stipulated 60 days after the resignation, violating relevant regulations [1] - The exchange emphasized the importance of compliance with laws and regulations, urging the company and its management to ensure accurate and timely information disclosure to prevent similar incidents in the future [1] Group 2 - For the first half of 2025, the revenue composition of Hengbang Co. was as follows: precious metal smelting accounted for 72.22%, precious metal mining for 21.98%, mineral powder sales for 2.85%, non-ferrous metal trading for 1.57%, and chemical production for 1.09% [2] - As of the report date, Hengbang Co. had a market capitalization of 14.7 billion yuan [3] - The company faced significant challenges as its core product was impacted by the first major customer reducing purchases due to self-supply, leading to a loss exceeding 100 million yuan shortly after its listing [3]

Core Viewpoint - The company received a corrective action decision from the Shandong Regulatory Bureau of the China Securities Regulatory Commission due to non-compliance with independent director regulations [1] Group 1: Regulatory Compliance - The decision states that two independent directors resigned on August 11, 2025, due to the expiration of their terms [1] - The resignation resulted in the proportion of independent directors on the board falling below one-third [1] - The company failed to complete the re-election of independent directors within sixty days from the date of resignation, violating the Independent Director Management Measures [1]

Core Viewpoint - The company, Hengbang Co., Ltd., has received administrative regulatory measures from the Shandong Securities Regulatory Bureau due to governance issues related to the resignation of independent directors and failure to timely disclose significant incidents [1][2] Group 1: Regulatory Actions - On November 25, Hengbang Co., Ltd. was ordered to rectify governance issues after two independent directors resigned, leading to a board composition that fell below the required one-third independent director threshold [1] - The company has been instructed to submit a written rectification report within a specified timeframe as part of the regulatory measures [2] Group 2: Previous Incidents - In August 2024, the company faced scrutiny for a safety incident involving a copper spillage that resulted in personnel injuries, with delayed disclosure of the incident and subsequent production suspension [2] - The company had previously received a regulatory letter from the Shenzhen Stock Exchange regarding the same safety incident, highlighting issues with timely information disclosure [2] Group 3: Company Response - Hengbang Co., Ltd. has acknowledged the regulatory decision and expressed commitment to learning from the issues raised, emphasizing the importance of compliance with laws and regulations to prevent future violations [2] - The company asserts that the regulatory measures will not impact its operational or financial status and is focused on maintaining compliance and protecting shareholder interests [2]

Core Viewpoint - The company, Hengbang Co., Ltd. (002237.SZ), has received a corrective action order from the Shandong Regulatory Bureau of the China Securities Regulatory Commission due to non-compliance with regulations regarding independent directors [1] Group 1: Regulatory Compliance - The order states that two independent directors resigned on August 11, 2025, due to the expiration of their terms, resulting in the proportion of independent directors on the board falling below one-third [1] - The company failed to complete the re-election of independent directors within sixty days from the date of resignation, which violates Article 15 of the "Measures for the Administration of Independent Directors of Listed Companies" (CSRC Order No. 227) [1]

Core Viewpoint - The company received a regulatory decision from the Shandong Securities Regulatory Bureau due to non-compliance with independent director management regulations, specifically regarding the resignation of two independent directors and failure to complete their replacement within the stipulated time frame [1] Summary by Relevant Sections Regulatory Action - The Shandong Securities Regulatory Bureau issued a decision requiring the company to rectify its governance issues due to the resignation of two independent directors, which will reduce the proportion of independent directors on the board to below one-third [1] - The company failed to complete the election of new independent directors within sixty days from the resignation date, violating the Independent Director Management Measures [1] Compliance Issues - The actions taken by the company are recorded in the securities and futures market integrity database, indicating a formal acknowledgment of the compliance breach [1]

| 证券代码：002237 | 证券简称：恒邦股份 | 公告编号：2025-112 | | --- | --- | --- | | 债券代码：127086 | 债券简称：恒邦转债 | | 山东恒邦冶炼股份有限公司 关于提前赎回恒邦转债实施暨即将停止转股的重要提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 重要内容提示： 1.最后转股日：2025 年 11 月 27 日 2025 年 11 月 27 日是"恒邦转债"最后一个转股日，当日收市前，持有"恒邦 转债"的投资者仍可进行转股；2025 年 11 月 27 日收市后，未转股的"恒邦转债" 将停止转股。 2.截至 2025 年 11 月 25 日收市后，距离"恒邦转债"停止转股并赎回仅剩 2 个 交易日。山东恒邦冶炼股份有限公司（以下简称"公司"）特别提醒"恒邦转债" 持有人务必认真阅读本公告，充分了解相关风险，注意最后转股时间，审慎作出投 资决策。 特别提示： 1."恒邦转债"赎回价格：100.28 元/张（含当期应计利息，当期年利率为 0.6%， 且当期利息含税），扣税后的赎回价格以中国证券登 ...

| 证券代码：002237 | 证券简称：恒邦股份 | 公告编号：2025-113 | | --- | --- | --- | | 债券代码：127086 | 债券简称：恒邦转债 | | 一、《决定书》的具体内容 山东恒邦冶炼股份有限公司： 经查，你公司两名独立董事因任期届满于 2025 年 8 月 11 日辞职，将导致独立 董事占董事会成员的比例低于三分之一。你公司未能自独立董事提出辞职之日起六 十日内完成补选。上述行为不符合《上市公司独立董事管理办法》（证监会令第 227 号）第十五条的规定。 山东恒邦冶炼股份有限公司 关于公司收到山东监管局行政监管措施决定书的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 山东恒邦冶炼股份有限公司（以下简称"公司"）于 2025 年 11 月 25 日收到中 国证券监督管理委员会山东监管局下发的《关于对山东恒邦冶炼股份有限公司采取 责令改正措施的决定》（〔2025〕95 号）（以下简称"《决定书》"）。现将有关 情况公告如下： 根据《上市公司独立董事管理办法》（证监会令第 227 号）第四十四条的规定， 我局决定对 ...

证券日报网讯 11月24日晚间，恒邦股份发布公告称，根据安排，截至2025年11月27日收市后仍未转股 的"恒邦转债"将被强制赎回。本次赎回完成后，"恒邦转债"将在深圳证券交易所（以下简称"深交所"） 摘牌，特提醒"恒邦转债"债券持有人注意在限期内转股。债券持有人持有的"恒邦转债"如存在被质押或 被冻结的，建议在停止交易日前解除质押或冻结，以免出现因无法转股而被赎回的情形。 （文章来源：证券日报） ...

Core Viewpoint - The precious metals sector experienced a decline of 0.7% on November 24, with Chifeng Gold leading the drop. The Shanghai Composite Index closed at 3836.77, up 0.05%, while the Shenzhen Component Index closed at 12585.08, up 0.37% [1]. Group 1: Market Performance - The precious metals sector saw a net outflow of 44.1 million yuan from institutional investors and 60.5 million yuan from speculative funds, while retail investors had a net inflow of 105 million yuan [3][4]. - The closing prices and performance of key stocks in the precious metals sector included: - Hunan Gold: 21.80, up 2.11% - Western Gold: 25.88, up 1.85% - Sichuan Gold: 26.52, up 0.15% - Chifeng Gold: 29.77, down 1.59% [1][3]. Group 2: Fund Flow Analysis - The main fund inflows and outflows for selected stocks were as follows: - Hunan Gold: Main net inflow of 86.04 million yuan, retail net outflow of 74.25 million yuan - Shandong Gold: Main net inflow of 16.22 million yuan, retail net inflow of 0.65 million yuan - Chifeng Gold: Main net outflow of 34.42 million yuan, retail net inflow of 28.10 million yuan [4]. Group 3: ETF Information - The gold stock ETF (Product Code: 159562) tracking the CSI Hong Kong and Shanghai Gold Industry Index has seen a decline of 3.71% over the past five days, with a price-to-earnings ratio of 22.90 times. The latest share count is 1.23 billion, down by 3 million shares, with a net subscription and redemption of -6.34 million yuan [6].